P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies

Grazia Gargano, Sabino Ciavarella, Angela Maria Quinto et al.|Clinical Lymphoma Myeloma & Leukemia|2023

Cited by 0